GlassScriptPhysician profile
Ratnam Jain
NPI 1679583546
$848.47
in general payments reported to CMS, 2019-2025
15 companies · $71.21 in 2025
The $71.21 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.25 · 2020: $25.20 · 2021: $62.62 · 2022: $100 · 2023: $349 · 2024: $165 · 2025: $71.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $228.05 | 2023 | Watchman Flx |
| Astellas Pharma US INC | $161.01 | 2023-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $95.74 | 2021-2022 | |
| Organon LLC | $50.82 | 2024 | |
| Medtronic Vascular, INC. | $47.14 | 2019 | |
| Exeltis, USA INC. | $41.63 | 2020-2025 | Slynd |
| Dysis Medical, INC. | $38.62 | 2022 | |
| Sumitomo Pharma America, INC. | $33.38 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $29.29 | 2021-2023 | |
| Kerecis Limited | $28.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Therapeuticsmd, INC. | $27.55 | 2019-2020 | |
| Si-Bone, INC. | $20.70 | 2025 | |
| Aspira Women'S Health INC | $18.24 | 2025 | Ova1 |
| Agile Therapeutics, INC. | $14.21 | 2022 | |
| Allergan, INC. | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ratnam Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.